SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?

To: Jim B who wrote (4169)9/22/1998 8:08:00 PM
From: OFW  Respond to of 5402
 
Thanks Jim. Listening in now! Offie (eom)



To: Jim B who wrote (4169)9/22/1998 8:14:00 PM
From: OFW  Read Replies (1) | Respond to of 5402
 
One of the things brought to light was that blood transfusions are not acceptable to certain religious beliefs --- our good Dr. D says that the product is fully acceptable to these religious beliefs.

Also said he believes the product can be on the shelves within three years.

Offie



To: Jim B who wrote (4169)9/22/1998 8:22:00 PM
From: OFW  Read Replies (2) | Respond to of 5402
 
One hundred percent replacement has been done in trials. Need to complete animal trials and then into human trials. Only three companies left in the horse race for development of the product.

A question (James) about the company - Dr. D describes Sanquine as publicly traded and on the electronic bulletin board as SGNC.

Jim B. was that you?

Offie


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News